Laerdal Medical India Profile
Key Indicators
- Authorised Capital ₹ 6.80 M
- Paid Up Capital ₹ 6.60 M
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 84.78%
- Profit Growth 127.55%
- Ebitda 109.64%
- Net Worth 86.23%
- Total Assets 74.53%
About Laerdal Medical India
Laerdal Medical India Private Limited (LMIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 31 May 2010 and has a history of 14 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.80 M and a paid-up capital of Rs 6.60 M, as per Ministry of Corporate Affairs (MCA) records.
Egil Mathisen, Unni Silkoset, Tor Bryne, and One other member serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85100MH2010PTC335728
-
Company No.
335728
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 May 2010
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Laerdal Medical India Private Limited offer?
Laerdal Medical India Private Limited offers a wide range of products and services, including Medical Consultants & Clinics, Health Care Service, Forceps & Graspers, Surgical Accessories, Surgical & ICU Equipments, Oxygen Mask, Corporate and Soft Skills Training, Skill Development Services, Laboratory & Lab Equipment, Human Anatomical Models.
Who are the key members and board of directors at Laerdal Medical India?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Egil Mathisen
|
Director | 31-May-2010 | Current |
|
Unni Silkoset
|
Director | 15-Nov-2017 | Current |
|
Tor Bryne
|
Director | 05-Feb-2020 | Current |
Sanjeev Singh
|
Director | 21-Aug-2020 | Current |
Financial Performance of Laerdal Medical India.
Laerdal Medical India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 84.78% increase. The company also saw a substantial improvement in profitability, with a 127.55% increase in profit. The company's net worth Soared by an impressive increase of 86.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Laerdal Medical India?
In 2023, Laerdal Medical India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Laerdal Medical India?
Laerdal Medical India has a workforce of 39 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Laerdal Medical India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Laerdal Medical India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
